This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

HealthDay News — Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics, 2025 report published ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...